Literature DB >> 11903757

Self-restriction of medications due to cost in seniors without prescription coverage.

M A Steinman1, L P Sands, K E Covinsky.   

Abstract

OBJECTIVE: Little is known about patients who skip doses or otherwise avoid using their medications because of cost. We sought to identify which elderly patients are at highest risk of restricting their medications because of cost, and how prescription coverage modifies this risk. DESIGN AND PARTICIPANTS: Cross-sectional study from the 1995-1996 wave of the Survey of Asset and Health Dynamics Among the Oldest Old, a population-based survey of Americans age 70 years and older. MEASUREMENTS: Subjects were asked the extent of their prescription coverage, and whether they had taken less medicine than prescribed for them because of cost over the prior 2 years. We used bivariate and multivariate analyses to identify risk factors for medication restriction in subjects who lacked prescription coverage. Among these high-risk groups, we then examined the effect of prescription coverage on rates of medication restriction. MAIN
RESULTS: Of 4,896 seniors who regularly used prescription medications, medication restriction because of cost was reported by 8% of subjects with no prescription coverage, 3% with partial coverage, and 2% with full coverage (P <.01 for trend). Among subjects with no prescription coverage, the strongest independent predictors of medication restriction were minority ethnicity (odds ratio [OR], 2.9 compared with white ethnicity; 95% confidence interval [95% CI], 2.0 to 4.2), annual income <$10,000 (OR, 3.8 compared with income > or =$20,000; 95% CI, 2.4 to 6.1), and out-of-pocket prescription drug costs >$100 per month (OR, 3.3 compared to costs < or =$20; 95% CI, 1.5 to 7.2). The prevalence of medication restriction in members of these 3 risk groups was 21%, 16%, and 13%, respectively. Almost half (43%) of subjects with all 3 risk factors and no prescription coverage reported restricting their use of medications. After multivariable adjustment, high-risk subjects with no coverage had 3 to 15 times higher odds of medication restriction than subjects with partial or full coverage (P <.01).
CONCLUSIONS: Medication restriction is common in seniors who lack prescription coverage, particularly among certain vulnerable groups. Seniors in these high-risk groups who have prescription coverage are much less likely to restrict their use of medications.

Entities:  

Mesh:

Year:  2001        PMID: 11903757      PMCID: PMC1495305     

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  38 in total

1.  Insurance coverage for prescription drugs: effects on use and expenditures in the Medicare population.

Authors:  L A Lillard; J Rogowski; R Kington
Journal:  Med Care       Date:  1999-09       Impact factor: 2.983

Review 2.  Access and cost implications of state limitations on Medicaid reimbursement for pharmaceuticals.

Authors:  S O Schweitzer; S R Shiota
Journal:  Annu Rev Public Health       Date:  1992       Impact factor: 21.981

3.  Report of the Task Force on the Availability of Cardiovascular Drugs to the Medically Indigent.

Authors:  H P Dustan; L R Caplan; C L Curry; A C De Leon; F L Douglas; W Frishman; M N Hill; R L Washington; S Steigerwalt; N B Shulman
Journal:  Circulation       Date:  1992-02       Impact factor: 29.690

4.  Patients as reliable reporters of medical care process. Recall of ambulatory encounter events.

Authors:  J B Brown; M E Adams
Journal:  Med Care       Date:  1992-05       Impact factor: 2.983

5.  Predictors of recall of medication regimens and recommendations for lifestyle change in elderly patients.

Authors:  K Rost; D Roter
Journal:  Gerontologist       Date:  1987-08

6.  Racial differences in the elderly's use of medical procedures and diagnostic tests.

Authors:  J J Escarce; K R Epstein; D C Colby; J S Schwartz
Journal:  Am J Public Health       Date:  1993-07       Impact factor: 9.308

7.  Validity of self-reported hospital admission in a prospective study.

Authors:  A Norrish; D North; P Kirkman; R Jackson
Journal:  Am J Epidemiol       Date:  1994-11-15       Impact factor: 4.897

8.  Effects of a limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia.

Authors:  S B Soumerai; T J McLaughlin; D Ross-Degnan; C S Casteris; P Bollini
Journal:  N Engl J Med       Date:  1994-09-08       Impact factor: 91.245

9.  Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes.

Authors:  S B Soumerai; D Ross-Degnan; J Avorn; T j McLaughlin; I Choodnovskiy
Journal:  N Engl J Med       Date:  1991-10-10       Impact factor: 91.245

10.  Agreement between patient self-reports and medical records for Pap smear histories.

Authors:  M T McKenna; M Speers; K Mallin; R Warnecke
Journal:  Am J Prev Med       Date:  1992 Sep-Oct       Impact factor: 5.043

View more
  60 in total

1.  Medicare prescription coverage and congressional gridlock.

Authors:  S B Soumerai; A S Adams; D Ross-Degnan
Journal:  J Gen Intern Med       Date:  2001-12       Impact factor: 5.128

2.  The best of JGIM.

Authors:  Eric B Bass
Journal:  J Gen Intern Med       Date:  2002-12       Impact factor: 5.128

3.  Glycemic self-monitoring and insurance coverage.

Authors:  Michele Heisler
Journal:  CMAJ       Date:  2004-07-06       Impact factor: 8.262

4.  Use of guideline-recommended therapies for heart failure in the Medicare population.

Authors:  Lisa D DiMartino; Alisa M Shea; Adrian F Hernandez; Lesley H Curtis
Journal:  Clin Cardiol       Date:  2010-07       Impact factor: 2.882

5.  Potentially inappropriate prescribing in Canada relative to the US.

Authors:  Paula A Rochon; Christopher J Lane; Susan E Bronskill; Kathy Sykora; Geoffrey M Anderson; Muhammad M Mamdani; Jerry H Gurwitz; Irfan A Dhalla
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

6.  The National e-Prescribing Patient Safety Initiative: removing one hurdle, confronting others.

Authors:  Michael A Fischer
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

7.  Variation in drug prices at pharmacies: are prices higher in poorer areas?

Authors:  Walid F Gellad; Niteesh K Choudhry; Mark W Friedberg; M Alan Brookhart; Jennifer S Haas; William H Shrank
Journal:  Health Serv Res       Date:  2008-11-04       Impact factor: 3.402

8.  Out-of-pocket prices of opioid analgesics in the United States, 1999-2004.

Authors:  Benjamin M Craig; Scott A Strassels
Journal:  Pain Med       Date:  2009-12-09       Impact factor: 3.750

9.  The validity of a questionnaire on medicines used in health care practice: comparison of a questionnaire and computerized medical record survey.

Authors:  Ahmad Al-Windi
Journal:  Eur J Clin Pharmacol       Date:  2003-07-04       Impact factor: 2.953

10.  Barriers to patient-physician communication about out-of-pocket costs.

Authors:  G Caleb Alexander; Lawrence P Casalino; Chien-Wen Tseng; Diane McFadden; David O Meltzer
Journal:  J Gen Intern Med       Date:  2004-08       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.